{"product_id":"tirzepatide-30-mg-self-mix","title":"Noventra Pharma Tirzepatide 30 mg Self-Mix","description":"\u003ch1 data-pm-slice=\"1 1 []\"\u003e\u003cspan\u003eNoventra Pharma Tirzepatide 30 mg — Multidose Vial Kit\u003c\/span\u003e\u003c\/h1\u003e\n\u003cp\u003e\u003cstrong\u003e\u003cspan\u003eDual-Receptor Research | Metabolic Health | Weight-Management Research\u003c\/span\u003e\u003c\/strong\u003e\u003c\/p\u003e\n\u003ch2\u003e\u003cspan\u003eProduct Overview\u003c\/span\u003e\u003c\/h2\u003e\n\u003cp\u003e\u003cspan\u003eNoventra Pharma Tirzepatide 30 mg is a vial-format product labelled as containing a 30 mg multidose ampule, accompanied by a 2 ml ampule of bacteriostatic water.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eTirzepatide is a dual GIP and GLP-1 receptor agonist studied for its role in appetite regulation, blood-glucose control and body-weight management. Its activity across these two metabolic hormone pathways has made it an important focus of clinical research into obesity and type 2 diabetes.\u003c\/span\u003e\u003c\/p\u003e\n\u003ch2\u003e\u003cspan\u003eKey Research Findings\u003c\/span\u003e\u003c\/h2\u003e\n\u003cp\u003e\u003cspan\u003eClinical trials have demonstrated several important effects of tirzepatide in studied patient populations:\u003c\/span\u003e\u003c\/p\u003e\n\u003cul data-spread=\"false\"\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cstrong\u003e\u003cspan\u003eBody-weight reduction:\u003c\/span\u003e\u003c\/strong\u003e\u003cspan\u003e In the 72-week SURMOUNT-1 trial, average body-weight reductions ranged from 15.0% to 20.9% across the three tirzepatide groups in the primary analysis.\u003c\/span\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cstrong\u003e\u003cspan\u003eAppetite regulation:\u003c\/span\u003e\u003c\/strong\u003e\u003cspan\u003e Tirzepatide influences metabolic signalling pathways involved in appetite and energy intake.\u003c\/span\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cstrong\u003e\u003cspan\u003eBlood-glucose control:\u003c\/span\u003e\u003c\/strong\u003e\u003cspan\u003e Clinical research has demonstrated improvements in glycaemic control among people with type 2 diabetes.\u003c\/span\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cstrong\u003e\u003cspan\u003eCardiometabolic markers:\u003c\/span\u003e\u003c\/strong\u003e\u003cspan\u003e Trials reported improvements in waist circumference, blood pressure and several blood lipid measurements.\u003c\/span\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003cspan\u003eThese findings reflect outcomes from controlled clinical trials using specified tirzepatide formulations and treatment protocols. They do not establish equivalent results for this particular product.\u003c\/span\u003e\u003c\/p\u003e","brand":"Noventra","offers":[{"title":"Default Title","offer_id":51026680873185,"sku":null,"price":1440.0,"currency_code":"ZAR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0825\/1935\/9713\/files\/Noventra-Pharma-Tirzepatide-30mg-Multi-Dose-Ampule-Self-Mix-card-768x538.png?v=1793173278","url":"https:\/\/health-tech.co.za\/products\/tirzepatide-30-mg-self-mix","provider":"Health Tech","version":"1.0","type":"link"}